Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence and factors associated with tuberculosis infection in India.
Selvaraju S, Velayutham B, Rao R, Rade K, Thiruvengadam K, Asthana S, Balachandar R, Bangar SD, Bansal AK, Bhat J, Chopra V, Das D, Dutta S, Devi KR, Dwivedi GR, Kalliath A, Laxmaiah A, Madhukar M, Mahapatra A, Mohanty SS, Rangaraju C, Turuk J, Menon PA, Krishnan R, Singh M, Sekar K, Robinson A, Turuk A, Krishnan NN, Srinivasan N, Rexy C, Suresh M, Hanna LE, Choudhury AH, Parmar M, Ramachandran R, Kumar N, Joshi RP, Narasimhaiah S, Chandrasekaran P, Khan AM, Panda S, Bhargava B; National TB Prevalence Survey Group. Selvaraju S, et al. Among authors: ramachandran r. J Infect Public Health. 2023 Dec;16(12):2058-2065. doi: 10.1016/j.jiph.2023.10.009. Epub 2023 Oct 13. J Infect Public Health. 2023. PMID: 37948837 Free article.
Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India.
Moonan PK, Nair SA, Agarwal R, Chadha VK, Dewan PK, Gupta UD, Ho CS, Holtz TH, Kumar AM, Kumar N, Kumar P, Maloney SA, Mase SR, Oeltmann JE, Paramasivan CN, Parmar MM, Rade KK, Ramachandran R, Rao R, Salhorta VS, Sarin R, Sarin S, Sachdeva KS, Selvaraju S, Singla R, Surie D, Tonsing J, Tripathy SP, Khaparde SD. Moonan PK, et al. Among authors: ramachandran r. BMJ Glob Health. 2018 Oct 8;3(5):e001135. doi: 10.1136/bmjgh-2018-001135. eCollection 2018. BMJ Glob Health. 2018. PMID: 30364389 Free PMC article.
Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial.
Swaminathan S, Menon PA, Gopalan N, Perumal V, Santhanakrishnan RK, Ramachandran R, Chinnaiyan P, Iliayas S, Chandrasekaran P, Navaneethapandian PD, Elangovan T, Pho MT, Wares F, Paranji Ramaiyengar N. Swaminathan S, et al. Among authors: ramachandran r. PLoS One. 2012;7(12):e47400. doi: 10.1371/journal.pone.0047400. Epub 2012 Dec 14. PLoS One. 2012. PMID: 23251327 Free PMC article. Clinical Trial.
Estimation of tuberculosis incidence at subnational level using three methods to monitor progress towards ending TB in India, 2015-2020.
Jeyashree K, Thangaraj J, Rade K, Modi B, Selvaraju S, Velusamy S, Akhil S, Vijayageetha M, Sudha Rani D, Sabarinathan R, Manikandanesan S, Elumalai R, Natarajan M, Joseph B, Mahapatra A, Shamim A, Shah A, Bhardwaj A, Purty A, Vadera B, Sridhar A, Chowdhury A, Shafie A, Choudhury A, Dhrubjyoti D, Solanki H, Sirmanwar K, Khaparde K, Parmar M, Dahiya N, Debdutta P, Ahmed Q, Ramachandran R, Prasad R, Shinde R, Baruah R, Chauhan S, Bharaswadkar S, Achanta S, Sharath BN, Balakrishnan S, Chandra S, Khumukcham S, Mandal S, Chalil S, Shah V, Roddawar V, Rao R, Sachdeva K, Murhekar M; Subnational TB claims verification group. Jeyashree K, et al. Among authors: ramachandran r. BMJ Open. 2022 Jul 28;12(7):e060197. doi: 10.1136/bmjopen-2021-060197. BMJ Open. 2022. PMID: 35902192 Free PMC article.
Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.
Swaminathan S, Padmapriyadarsini C, Venkatesan P, Narendran G, Ramesh Kumar S, Iliayas S, Menon PA, Selvaraju S, Pooranagangadevi NP, Bhavani PK, Ponnuraja C, Dilip M, Ramachandran R. Swaminathan S, et al. Among authors: ramachandran r. Clin Infect Dis. 2011 Oct;53(7):716-24. doi: 10.1093/cid/cir447. Clin Infect Dis. 2011. PMID: 21890776 Clinical Trial.
Evolutionary journey of programmatic services and treatment outcomes among drug resistant tuberculosis (DR-TB) patients under National TB Elimination Programme in India (2005-2020).
Sachdeva KS, Parmar M, Patel Y, Gupta R, Rathod S, Chauhan S, Anand S, Ramachandran R. Sachdeva KS, et al. Among authors: ramachandran r. Expert Rev Respir Med. 2021 Jul;15(7):885-898. doi: 10.1080/17476348.2021.1850277. Epub 2021 Jan 21. Expert Rev Respir Med. 2021. PMID: 33307889 Review.
Transitioning to daily treatment for drug-sensitive TB in India.
Sachdeva KS, Shah A, Rade K, Ramachandran R, Sreenivas A, Parmar M, Ghedia M, Salhotra VS, Khaprde SD, Prasad J. Sachdeva KS, et al. Among authors: ramachandran r. Indian J Tuberc. 2015 Oct;62(4):239-42. doi: 10.1016/j.ijtb.2015.11.005. Epub 2016 Jan 27. Indian J Tuberc. 2015. PMID: 26970467
Is one sputum specimen as good as two during follow-up cultures for monitoring multi drug resistant tuberculosis patients in India?
Nagaraja SB, Kumar AM, Sachdeva KS, Ramachandran R, Satyanarayana S, Bansal A, Parmar M, Chadha S, Nair S, Kumar A, Hinderaker SG, Edginton M, Dewan PK. Nagaraja SB, et al. Among authors: ramachandran r. PLoS One. 2012;7(9):e45554. doi: 10.1371/journal.pone.0045554. Epub 2012 Sep 27. PLoS One. 2012. PMID: 23029092 Free PMC article.
Comprehensive assessment of invalid and indeterminate results in Truenat MTB-RIF testing across sites under the national TB elimination program of India.
Gopalaswamy R, Kumar N, Vashistha H, Rajendran P, Kayesth J, Peravali CJ, Kashyap S, Ghosh S, Yumo H, Moore M, Anand S, Ramachandran R, Alavadi U, Saini S, Shanmugam S. Gopalaswamy R, et al. Among authors: ramachandran r. Front Public Health. 2023 Oct 10;11:1255756. doi: 10.3389/fpubh.2023.1255756. eCollection 2023. Front Public Health. 2023. PMID: 37886056 Free PMC article.
Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial.
Gopalan N, Santhanakrishnan RK, Palaniappan AN, Menon PA, Lakshman S, Chandrasekaran P, Sivaramakrishnan GN, Reddy D, Kannabiran BP, Agiboth HKK, Krishnamoorthy V, Rathinam S, Chockalingam C, Manoharan T, Ayyamperumal M, Jayanthi N, Satagopan K, Narayanan R, Krishnaraja R, Sathiyavelu S, Kesavamurthy B, Suresh C, Selvachitiram M, Arasan G, Susaimuthu S, Rathinam P, Angamuthu P, Jayabal L, Murali L, Ramachandran R, Tripathy SP, Swaminathan S. Gopalan N, et al. Among authors: ramachandran r. JAMA Intern Med. 2018 Apr 1;178(4):485-493. doi: 10.1001/jamainternmed.2018.0141. JAMA Intern Med. 2018. PMID: 29507938 Free PMC article. Clinical Trial.
1,326 results